Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years

Marcello Covino1, Giuseppe De Matteis2, Michele Santoro1

  • 1Emergency Department, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Insights

In elderly patients (≥80 years) with coronavirus disease 2019 (COVID-19), severe dementia is a significant risk factor for death. Severe COVID-19 symptoms like low oxygen saturation and high lactate dehydrogenase indicate rapid progression to mortality.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) disproportionately affects elderly individuals.
  • Understanding prognostic factors in patients aged 80 years and older is crucial for risk stratification and management.

Purpose of the Study:

  • To describe the clinical presentation of COVID-19 in patients aged 80 years and older.
  • To identify prognostic factors and stratify risk in this vulnerable population.

Main Methods:

  • A single-center, retrospective observational study of 69 patients (aged 80-98 years) admitted for confirmed COVID-19.
  • Exclusion of asymptomatic patients; analysis of clinical records from March 2020.
  • Uni- and multivariate Cox regression analysis to identify risk factors for death.

Main Results:

  • The study cohort included 69 patients, with a median age of 84 years; 53.6% were male.
  • 20.3% had mild, 43.5% severe, and 36.2% critical COVID-19 disease.
  • At 30-day follow-up, 33.3% of patients had died. Independent risk factors for death included severe dementia, low oxygen saturation (pO2 ≤90), and elevated lactate dehydrogenase (>464 U/L).

Conclusions:

  • Age alone may not be the primary determinant of mortality risk in patients aged 80 years and older with COVID-19.
  • Severe dementia emerged as a significant risk factor.
  • Severe COVID-19 presentation, indicated by low oxygen saturation and high lactate dehydrogenase upon admission, is linked to rapid disease progression and mortality in this age group.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
132
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
131
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
123
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
173
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
155